digital currency negative interest rates searches

Backbone Technology: The holding subsidiary recently signed a strategic cooperation agreement on intelligent robots. Backbone Technology (002779) said on the interactive platform on December 12 that recently, Jiangsu Jianmi, the holding subsidiary of the company, signed strategic cooperation agreements with Dongsheng Zhilian and Nanjing Ji Rong respectively, working together to develop and apply automation, visualization and intelligent robots, and promoting the application and development of intelligent technologies in a wider range of fields. Jiangsu Jianmi's Lingrui P1 quadruped robot dog can be used for industrial park management, fire control and public security, daily inspection of power grid and electric power, and inspection of special operation scenes such as smelting enterprises and hazardous chemicals.The individual pension system has been extended to the whole country. (Xinhua News Agency)The ethylene plant of ExxonMobil Huizhou Ethylene Phase I Project entered the commissioning stage, and ExxonMobil China announced that in December 2024, the 1.6 million tons ethylene plant of ExxonMobil Huizhou Ethylene Phase I Project was handed over to China and entered the commissioning stage in an all-round way. ExxonMobil Huizhou Ethylene Project is located in Huizhou Daya Bay Petrochemical Park. The first phase of the project mainly includes ethylene plants, high-end polyethylene and polypropylene production plants in the middle and lower reaches, and supporting utilities, docks, storage and transportation and environmental protection facilities.

Wuhan Linkong Airport Capital Real Estate Co., Ltd. has set up a house demolition service business. The enterprise search APP shows that recently, Wuhan Linkong Airport Capital Real Estate Co., Ltd. was established with Zhou Cen as its legal representative and a registered capital of 500 million yuan. Its business scope includes: real estate development and operation; Construction project construction; Real estate consulting; Property management; Non-residential real estate lease; Housing lease; Hotel management; Land remediation services; Housing demolition services, etc. Enterprise investigation shows that the company is indirectly wholly-owned by Wuhan Linkong Airport State-owned Capital Holding Group Co., Ltd.The Nikkei 225 index closed at 39,881.10 points in early trading, up 1.29%.The personal pension system has been extended to the whole country. On December 12th, the Ministry of Human Resources and Social Security and other five departments issued the Notice on the Full Implementation of the Personal Pension System. Since December 15th, the personal pension system has been extended to the whole country from 36 pilot cities (regions). (Xinhua News Agency)

Evergrande Group and others were resumed execution by 320 million yuan. According to the information of legal proceedings, on December 11th, Evergrande Group Co., Ltd. added two pieces of resumption execution information, with a total execution amount of more than 322 million yuan, involving construction project contract disputes. The executors also included Hefei Yuetai Commercial Operation Management Co., Ltd. and Evergrande Real Estate Group Co., Ltd., and the enforcement court was the Baohe District People's Court in Hefei.Market news: South Korea's ruling party has elected a new party leader, and the new leader said that a presidential election may be held soon.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.